How Much Do We Know about Drug Resistance Due to PrEP Use? Analysis of Experts’ Opinion and Its Influence on the Projected Public Health Impact

@inproceedings{Dimitrov2016HowMD,
  title={How Much Do We Know about Drug Resistance Due to PrEP Use? Analysis of Experts’ Opinion and Its Influence on the Projected Public Health Impact},
  author={Dobromir T. Dimitrov and Marie-Claude Boily and Timothy B Hallett and Jan Albert and Charles Boucher and John W Mellors and Deenan Pillay and David A. M. C. van de Vijver},
  booktitle={PloS one},
  year={2016}
}
BACKGROUND Randomized controlled trials reported that pre-exposure prophylaxis (PrEP) with tenofovir and emtricitabine rarely selects for drug resistance. However, drug resistance due to PrEP is not completely understood. In daily practice, PrEP will not be used under the well-controlled conditions available in the trials, suggesting that widespread use of PrEP can result in increased drug resistance. METHODS We surveyed expert virologists with questions about biological assumptions regarding… CONTINUE READING
Related Discussions
This paper has been referenced on Twitter 15 times. VIEW TWEETS

From This Paper

Topics from this paper.

References

Publications referenced by this paper.

Acquired drug-resistance: Transmitted drug-resistance

Acquired drug-resistance: Transmitted drug-resistance

Similar Papers

Loading similar papers…